Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients

Abstract Objectives To address whether the use of methotrexate (MTX) and biological disease-modifying anti-rheumatic drugs (bDMARDs) impacts bone structure and biomechanical properties in patients with psoriatic arthritis (PsA). Methods This is a cross-sectional study in PsA patients receiving no DM...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	David Simon, Arnd Kleyer, Sara Bayat, Koray Tascilar, Eleni Kampylafka, Timo Meinderink, Louis Schuster, Ramona Petrov, Anna-Maria Liphardt, Juergen Rech, Georg Schett, Axel J. Hueber
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2019-07-01
Σειρά:	Arthritis Research & Therapy
Θέματα:	Psoriatic arthritis Bone Disease-modifying anti-rheumatic drugs Biological agents Methotrexate Computed tomography
Διαθέσιμο Online:	http://link.springer.com/article/10.1186/s13075-019-1938-3
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!